Megan Wanzo is the Director of Global Patient Inclusion and Recruitment at Bristol Myers Squibb, where she leads a global team focused on advancing patient inclusion and improving access to clinical trials. Her work involves developing strategies that connect patients and communities, healthcare professionals, research sites, and clinical development teams to support more inclusive and accessible clinical research. 

With over a decade of experience spanning global drug development, clinical operations, public health, policy, and community engagement, Megan has led Phase I–IV oncology clinical trials and contributed to advancing health equity and inclusive research strategies across different regions. 

Her academic background includes a doctorate in bioethics, a Master of Science, and MBA studies at the University of Chicago Booth School of Business, bringing together expertise in scientific research, ethics, and strategic leadership. 

Beyond the pharmaceutical industry, Megan helped lead a multimillion-dollar initiative funded by the US Centers for Disease Control and Prevention (CDC) through Well Being and Equity in the World, supporting community-driven approaches to public health challenges. She has also taught Public Health and Social Justice at Saint Louis University, where she received the 2024 Diversity and Social Justice Professor of the Year award. 

A central focus of her work is addressing the gap between clinical trial availability and meaningful patient access. She advocates for stronger partnerships, community engagement, and coordinated approaches to overcoming barriers related to geography, awareness, trust, and healthcare systems. 

Her professional commitment center’s on ensuring that advances in medical research translate into equitable opportunities and meaningful benefits for patients and communities worldwide.